Select Publications

Book Chapters

Penglase R; Sandler RD; Moore J; Snowden JA, 2021, 'Hematopoietic Stem Cell Transplantation for Rheumatoid Arthritis', in Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases, pp. 547 - 556, http://dx.doi.org/10.1201/9781315151366-58

Journal articles

Tiong IS; Wall M; Bajel A; Kalro A; Fleming S; Roberts AW; Thiagarajah N; Chua CC; Latimer M; Yeung D; Marlton P; Johnston A; Enjeti A; Fong CY; Cull G; Larsen S; Kennedy G; Schwarer A; Kipp D; Ramanathan S; Verner E; Tiley C; Morris E; Hahn U; Moore J; Taper J; Purtill D; Warburton P; Stevenson W; Murphy N; Tan P; Beligaswatte A; Mutsando H; Hertzberg M; Shortt J; Szabo F; Dunne K; Wei AH, 2024, 'How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials?', Blood Cancer Journal, 14, http://dx.doi.org/10.1038/s41408-024-00996-x

Thiagarajah N; Dowling MR; Dunne K; Aarons D; Collins J; Tran S; Fleming S; Sutrave G; Hiwase D; Fong CY; Hsu B; Purtill D; Watson A-M; Kennedy GA; Stevenson WS; Larsen SR; Moore J; Perera T; Ritchie DS; Wei A; Roberts AW; Hamad N; Bajel A, 2024, 'Real-World Patterns of Care and Outcomes for Non-Favourable Risk Acute Myeloid Leukemia Treated with Intensive Chemotherapy across Australia and New Zealand- Data Linkage between the ALLG National Blood Cancer Registry (NBCR) and the Australia and New Zealand Transplant and Cellular Therapy (ANZTCT) Registry', Blood, 144, pp. 3799 - 3799, http://dx.doi.org/10.1182/blood-2024-209389

Penglase R; Girgis L; Englert H; Ma D; Moore J, 2024, 'Australian rheumatologists' perception of autologous haemopoietic stem cell transplantation for the treatment of systemic sclerosis: a cross-sectional survey', Internal Medicine Journal, 54, pp. 1478 - 1482, http://dx.doi.org/10.1111/imj.16422

Gregory K; Hansen D; Penglase R; Apostolopoulos D; Ngian GS; Stevens W; Morrisroe K; Ferdowsi N; Ross L; Walker J; Cooley H; Youssef P; Tymms K; Host L; Proudman S; Moore J; Nikpour M; Sahhar J, 2024, 'Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy', Arthritis and Rheumatology, 76, pp. 1294 - 1302, http://dx.doi.org/10.1002/art.42850

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson AM; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2024, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies', Transplantation and Cellular Therapy, 30, pp. 334.e1 - 334.e7, http://dx.doi.org/10.1016/j.jtct.2023.11.018

Moore J; Milliken S; Dodds A; Ma D; Snowden J, 2024, 'James Crawford Biggs 1931-2023', Bone marrow transplantation, 59, pp. 291 - 292, http://dx.doi.org/10.1038/s41409-023-02170-6

Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J, 2023, 'Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant', Cytotherapy, 25, pp. 1271 - 1276, http://dx.doi.org/10.1016/j.jcyt.2023.08.010

McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2023, 'Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey', BMC Psychology, 11, http://dx.doi.org/10.1186/s40359-023-01204-4

Rajasekariah H; McCaughan G; Ma CKK; Gorrie N; Milliken S; Ma D; Fay K; Withers B; Hamad N; Birch S; Keogh A; Jabbour A; Hayward C; Macdonald P; Moore J, 2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319

McErlean G; Tapp C; Brice L; Pradhan A; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2023, 'Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey', Clinical Nursing Research, 32, pp. 1134 - 1144, http://dx.doi.org/10.1177/10547738231180337

Blennerhassett R; Othman J; Biscoe A; Kliman D; Mills G; Blyth E; Micklethwaite K; Kwan J; Bilmon I; Bhattacharyya A; Panicker S; Fay K; Milliken S; Ma D; Hamad N; Stevenson W; Arthur C; Moore J; Greenwood M; Gottlieb D; Kerridge I, 2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal, 53, pp. 1979 - 1986, http://dx.doi.org/10.1111/imj.16043

Moore J; Hamad N; Gottlieb D; Bajel A; Ritchie D; Yeung D; Greenwood M; Purtill D; Tran S; Solterbeck A; Aarons D; Kwan J, 2023, 'Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study', Blood Advances, 7, pp. 5554 - 5565, http://dx.doi.org/10.1182/bloodadvances.2023009840

Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Visweswaran M; Withers B; Moore J; Ma D; Sutton I, 2023, 'Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis', Clinical Immunology, 254, http://dx.doi.org/10.1016/j.clim.2023.109709

Fleming S; Reynolds J; Bajel A; Venn N; Kwan J; Moore J; Yeung D; Pati N; Leahy M; Kollipara S; Verner E; Berkahn L; Sutton R; Wei A; Greenwood M, 2023, 'P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH- B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL08 STUDY', HemaSphere, 7, pp. e811479d - e811479d, http://dx.doi.org/10.1097/01.hs9.0000968372.81147.9d

Penglase R; Girgis L; Englert H; Brennan X; Jabbour A; Kotlyar E; Ma D; Moore J, 2023, 'Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis', Journal of Scleroderma and Related Disorders, 8, pp. 87 - 100, http://dx.doi.org/10.1177/23971983221145639

Rees MJ; Dickinson M; Paterson J; Ng TF; Grigg A; Moore J; Blombery P; Seymour JF, 2023, 'Targeting the BRAF pathway in haematological diseases', Internal Medicine Journal, 53, pp. 845 - 849, http://dx.doi.org/10.1111/imj.16091

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255

Brennan X; Withers B; Jabbour A; Milliken S; Kotlyar E; Fay K; Ma D; Muthiah K; Hamad N; Dodds A; Bart N; Keogh A; Hayward C; Macdonald P; Moore J, 2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926

McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG, 2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, 199, pp. 190 - 204, http://dx.doi.org/10.1111/bjh.18295

Achini-Gutzwiller FR; Snowden JA; Corbacioglu S; Greco R; Alexander T; Badoglio M; Labopin M; Abinun M; Apte S; Arnold R; Domenech A; Brierley C; Burman J; Castilla-Llorente C; Cooper N; Daghia G; Daikeler T; del Papa N; de Vries-Bouwstra J; Farge D; Finke J; Hagglund H; Hawkey C; Henes J; Hiepe F; Jessop H; Kiely D; Kazmi M; Kirgizov K; Kramer E; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Ricart E; Rovira M; Saccardi R; Saif M; Sakellari I; Sharrack B; Snarski E; Scherer HU; Sossa C; Withers B; Wulffraat N; Zaccara E; Amrolia P; Ansari M; Balduzzi A; Dalassier A; Dalle JH; Diaz CH; Feuchtinger T; Locatelli F; Lucchini G; Galimard JE; Vincent MG; Handgretinger R; Kleinschmidt K; Lawitschka A; Martinez AP; Peters C; Rocha V; Ruggeri A; Sedlacek P; Svec P; Toporski J; Yesilipek A, 2022, 'Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation', British Journal of Haematology, 198, pp. 24 - 45, http://dx.doi.org/10.1111/bjh.18176

Penglase R; Englert H; Tymms K; Carr A; Ma D; Milliken S; Moore J, 2022, 'Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?', Bone Marrow Transplantation, 57, pp. 1207 - 1209, http://dx.doi.org/10.1038/s41409-022-01696-5

Hsu H; Seah V; Marriott D; Moore J, 2022, 'Enterococcus cecorum infective endocarditis in a patient with chronic myeloid leukaemia and cirrhosis', Pathology, 54, pp. 495 - 497, http://dx.doi.org/10.1016/j.pathol.2021.07.004

Kliman D; Tran S; Kennedy G; Curley C; McLean A; Gottlieb D; Kwan J; Ritchie D; Chee L; Spencer A; Purtill D; Bardy P; Larsen S; Chien N; Perera T; Greenwood M; Hamad N; Moore J, 2022, 'The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR', Bone Marrow Transplantation, 57, pp. 982 - 989, http://dx.doi.org/10.1038/s41409-022-01683-w

McErlean G; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2022, 'Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey', Journal of Cancer Survivorship, 16, pp. 432 - 444, http://dx.doi.org/10.1007/s11764-021-01038-2

Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.798300

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220, http://dx.doi.org/10.1002/acn3.51510

Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ, 2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.782935

Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072

Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; Ma DDF; Milliken S; Moore J; Purtill D; Szer J, 2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62, http://dx.doi.org/10.1111/imj.15128

Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028

Perram J; Mayson E; Tang C; Tran S; Aarons D; Dodds AJ; Fay K; Hamad N; Ma D; Milliken S; Withers B; Greenwood M; Stevenson WS; Arthur CK; Kerridge IH; Moore J, 2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147106

Fleming S; Reynolds J; Bajel A; Venn N; Kwan J; Moore J; Yeung DT; Pati N; Leahy MF; Nkyekyer J; Verner E; Berkahn L; Sutton R; Wei AH; Greenwood M, 2021, 'Sequential Blinatumomab with Reduced Intensity Chemotherapy in the Treatment of Older Adults with Newly Diagnosed Ph Negative B-Precursor Acute Lymphoblastic Leukemia - Interim Analysis of the Australasian Leukemia and Lymphoma Group ALL08 Study', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-151826

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson A-M; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2021, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry', Blood, 138, pp. 2929 - 2929, http://dx.doi.org/10.1182/blood-2021-149939

Mills G; Moore J; Cliff E; Fong CY; Mangalasseril S; Tiley C; Gilbertson M; Ku M; Bazargan A; Bryson M; Menzies Wojtowicz M; Sungala NP; Cunningham I; Tang C; Hamad N, 2021, 'Promising Real World Survival Data in Adult-Onset Langerhans Cell Histiocytosis: An Australasian Lymphoma Alliance 20 Year Retrospective Study', Blood, 138, pp. 2570 - 2570, http://dx.doi.org/10.1182/blood-2021-152131

Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2021, 'Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, 51, pp. 1869 - 1875, http://dx.doi.org/10.1111/imj.14973

Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115, http://dx.doi.org/10.1177/13524585211005660

Blennerhassett R; Moses JH; Coulits N; Horne A; Simpson J; Marshall J; Weston L; Moore J, 2021, 'Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele', Bone Marrow Transplantation, 56, pp. 2603 - 2605, http://dx.doi.org/10.1038/s41409-021-01402-x

Kennedy GA; Tey SK; Buizen L; Varelias A; Gartlan KH; Curley C; Olver SD; Chang K; Butler JP; Misra A; Subramoniapillai E; Morton AJ; Durrant S; Henden AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Paul SK; Hill GR, 2021, 'A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis', Blood, 137, pp. 1970 - 1979, http://dx.doi.org/10.1182/blood.2020009050

Murray DD; Zaunders J; Milliken ST; Mee Ling Munier C; Ford C; Orla Morrissey C; Visweswaran M; Avery S; Sasadeusz J; Kwan J; Desai S; Law M; Koelsch KK; Lewin SR; Moore J; Kelleher AD; Polizzotto MN; Munier ML; Law M, 2021, 'Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients with Human Immunodeficiency Virus (HIV)', Clinical Infectious Diseases, 72, pp. 1141 - 1146, http://dx.doi.org/10.1093/cid/ciaa748

McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9

McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8

Snowden JA; Styczyński J; Snarski E; Greco R; Badoglio M; Labopin M; Abinun M; Apte S; Arnold R; Boglione C; Brierley C; Burman J; Castilla-Llorente C; Cooper N; Daghia G; Daikeler T; del Papa N; de Vries-Bouwstra J; Farge D; Finke J; Hagglund H; Hawkey C; Henes J; Hiepe F; Jessop H; Kiely D; Kazmi M; Kirgizov K; Kramer E; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Ricart E; Rovira M; Saccardi R; Saif M; Sakellari I; Sharrack B; Scherer HU; Sossa C; Withers B; Wulffraat N; Zaccara E, 2021, 'Hematopoietic stem cell transplantation in autoimmune diseases: update from the EBMT Autoimmune Diseases Working Party with special reference to Poland', Acta Haematologica Polonica, 52, pp. 217 - 224, http://dx.doi.org/10.5603/AHP.2021.0043

Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2021, 'Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors', Journal of Psychosocial Oncology, 39, pp. 534 - 552, http://dx.doi.org/10.1080/07347332.2020.1870644

Brice L; McErlean G; Donovan C; Tapp C; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2020, 'Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study', European Journal of Oncology Nursing, 49, http://dx.doi.org/10.1016/j.ejon.2020.101845

Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131

Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, 136, pp. 5 - 5, http://dx.doi.org/10.1182/blood-2020-142209

Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030

Hendrawan K; Visweswaran M; Ma DDF; Moore JJ, 2020, 'Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 55, pp. 857 - 866, http://dx.doi.org/10.1038/s41409-019-0710-2

Sharrack B; Saccardi R; Alexander T; Manuela B; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro P; Rovira M; Sormani MP; Snowden J, 2020, 'Autologous haematopoietic stem cell transplantation in multiple sclerosis and other immune-mediated neurological diseases: guidelines and recommendations of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for Cellular Therapy (4540)', Neurology, 94, http://dx.doi.org/10.1212/wnl.94.15_supplement.4540


Back to profile page